Výsledky vyhledávání - "V, Guillem Porta"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic Value of Tumour-Infiltrating Lymphocytes Changes between Pre and Post-Neoadjuvant Treatment and in Residual Disease in Triple Negative Breast Cancer

Autor: J Gavilá, A Guerrero, JA Lopez-Guerrero, C. Herrero-Vicent, Amparo Ruiz-Simon, A Hernández-Serra, A. Calatrava, Miguel A. Ramirez, V Guillem-Porta

Publikováno v: Annals of Gynecology and Obstetrics. 3

Triple-negative breast cancer (TNBC) is a heterogeneous disease with different biological behaviours and aggressiveness. Cancer immune edition has been revealed as a major hallmark in cancer. In patients treated with neoadjuvant chemotherapy (NAC) it

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f905318f97dbbc17046e4fb6534997e3
https://doi.org/10.36959/468/466

Zobrazit plný text záznamu

Breakthrough cancer pain: review and calls to action to improve its management

Autor: A Gonzalo Gómez, C. Camps Herrero, J Terrasa Pons, N Díaz Fernández, V. Guillem Porta, A Salud, Norberto Batista, Y Escobar Álvarez, D Isla Casado

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname

In this paper, we review the current state of breakthrough cancer pain (BTcP) management. BTcP is a heterogeneous condition and a global problem for cancer patients. It is often managed suboptimally, which results in a negative outcome for patients,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dee2f3990fa096357d4d569540ff49a3
https://pubmed.ncbi.nlm.nih.gov/32002739

Zobrazit plný text záznamu

Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)

Autor: J. J. Reina Zoilo, D. Monge Martín, F. Caballero Martínez, A. Carrato Mena, C. Camps Herrero, M. Feijóo Saus, V. Guillem Porta, J. García-Foncillas López, R. Lopez Lopez, E. Aranda Aguilar, E. Díaz-Rubio García

Publikováno v: DDFV: Repositorio Institucional de la Universidad Francisco de Vitoria
Universidad Francisco de Vitoria
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname

Aims To prove if there is clinical inertia in the identification and treatment of episodes of breakthrough cancer pain (BTcP), comparing actual results from clinical practice with clinical oncologists’ prior perception. Design Observational and des

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d90e25a304c962dce20e2be39940990f
https://hdl.handle.net/10668/12819

Zobrazit plný text záznamu

Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study

Autor: Eduardo Díaz-Rubio, J.J. Cruz Hernandez, R. López López, E. Aranda Aguilar, V. Guillem Porta, A. Anton Torres, P. Khosravi-Shahi, Jesús García-Foncillas, C. Camps Herrero, A. Carrato Mena, M. Feyjoo Saus, P. Gascón Vilaplana

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)

[Purpose]: Breakthrough cancer pain (BTcP) has been shown to be a prevalent and poor prognostic factor for oncologic patients, which remain under diagnosed and undertreated. In 2012, the Spanish Society of Medical Oncology (SEOM) published a clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cda9f44ab64400a7b374de0a0f400c5
http://hdl.handle.net/10261/245020

Zobrazit plný text záznamu

Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists

Autor: Luis Paz-Ares, A. Blasco-Cordellat, Juan J. Cruz-Hernández, C. Caballero-Díaz, V. Guillem-Porta, P. Gascón-Vilaplana, M. Codes, J. A. Moreno-Nogueira, Alfredo Carrato, R. López-López, A. Antón-Torres, C. Camps-Herrero, Eduardo Díaz-Rubio

Publikováno v: Clinical and Translational Oncology. 16:914-920

The economic situation showed that the resources devoted to health spending are limited, making rationalisation of their consumption necessary. The relevance of pharmacoeconomic analyses is becoming crucial. The ECO Foundation, promoting the quality

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d3bf4a67dd557fe3912b750cd8e1f5
https://doi.org/10.1007/s12094-014-1170-1

Zobrazit plný text záznamu

Clinical practice evaluation of opioids induced constipation management in cancer patients: The EIO-Praxis project

Autor: A. Carrato Mena, M. Constenla Figueiras, V. Guillem Porta, C. Camps Herrero, Margarita Feyjoo, J. Garcia Foncillas, Pere Gascón, Javier Puente, E. Aranda Aguilar, R. López, E. Diaz Rubio, J.J. Cruz Hernandez, Antonio Antón

Publikováno v: Annals of Oncology. 30:v739

Background In 2017, the ECO Foundation (Excellence and Quality in Oncology) completed the EIO-50 project to learn about the diagnostic and treatment criteria of opioid-induced constipation (OIC) in cancer patients. The EIO-Praxis project was designed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66967fcfa257b6e57b38ed35bdeaf99a
https://doi.org/10.1093/annonc/mdz265.064

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání